Amustaline (S ‐303) treatment inactivates high levels of Chikungunya virus in red‐blood‐cell components

ConclusionChikungunya virus was previously shown to be inactivated by the PI technology using amotosalen and ultraviolet A light for the treatment of plasma and platelets. This new study demonstrates that S‐303/GSH can inactivate high titres of CHIKV in RBCs.

Source: Vox Sanguinis - January 4, 2018 Category: Hematology Authors: M. Aubry, A. Laughhunn, F. Santa Maria, M. C. Lanteri, A. Stassinopoulos, D. Musso Tags: Original Paper Source Type: research